bibliographic entry 4978118 [be/4978118]
https://w3id.org/oc/corpus/be/4978118

is a
content
  • Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK et al. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T. Am J Hematol 2015; 90: 524–528. PMID: 25753178
references